+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), by Service (Clinical Monitoring, Data Management), and Segment Forecasts, 2020 - 2027

  • ID: 4538855
  • Report
  • February 2020
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Covance Inc.
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • PAREXEL
  • Pharmaron.
  • MORE
The global healthcare contract research organization market size is expected to reach USD 62.1 billion by 2027, registering a CAGR of 6.6% over the forecast period. Increasing cost of drug development is expected to drive market demand over the forecast period. Rising cost of clinical trials and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost savings and quick patient recruitment.

The alarming rise in incidence rate of chronic as well as infectious diseases such as cancer and Alzheimer’s is anticipated to spur demand for effective and safe treatment options. For instance, according to WHO, chronic diseases such as respiratory disorders, diabetes, cancer, cardiovascular diseases, and other life-threatening diseases are likely to account for about 73.0% of global deaths and about 60.0% of global disease burden by 2020. This is compelling an increasing number of healthcare companies to turn to contract research organizations (CROs) for the numerous benefits they offer.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations. Some government organizations are also outsourcing their clinical trial activities to CROs so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines. For instance, in 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).

Further key findings from the study suggest:
  • Clinical trial services dominated the healthcare CRO market in 2019 owing to the fact that it comprises four elaborate phases, including human subjects. ICON GPHS, formerly ClinicalRM, provides staffing and clinical development services to multiple agencies such as NGOs, the U.S. Government, academic institutions, and other healthcare organizations
  • North America held a significant market share in 2019 due to the presence of several global players, who invest a major part of their revenue in research activities
  • Asia Pacific is anticipated to witness lucrative growth over the forecast period due to the reduced cost it offers in comparison to U.S and other developed economies. China, Japan and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence
  • Key players in the market include IQVIA, Covance, Pharmaceutical Product Development, LLC (PPD), PAREXEL, Pharmaron, Syneos Health, Charles River Laboratories (CRL), ICON plc, Medidata Solutions, and GVK Biosciences Private Limited.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Covance Inc.
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • PAREXEL
  • Pharmaron.
  • MORE
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. Internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Healthcare CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. Regulatory Framework
3.4.1. Reimbursement framework
3.4.2. Standards & Compliances
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.6. Healthcare CRO: Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power:
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from new entrant:
3.6.1.5. Competitive rivalry:
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
3.6.3. Major Deals & Strategic Alliances Analysis
3.6.3.1. Joint Ventures
3.6.3.2. Mergers & Acquisitions
3.6.3.3. Licensing & Partnership
3.6.3.4. Technology Collaborations
3.6.3.5. Strategic Divestments

Chapter 4. Healthcare CRO Market: Segment Analysis, By Type, 2016 - 2027 (USD Million)
4.1. Type market share analysis, 2019 & 2027
4.2. Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.3.1. Drug Discovery
4.3.1.1. Target validation
4.3.1.2. Lead identification
4.3.1.3. Lead optimization
4.3.2. Pre-Clinical
4.3.3. Clinical
4.3.3.1. Phase I trial services
4.3.3.2. Phase II trial services
4.3.3.3. Phase III trial services
4.3.3.4. Phase IV trial services

Chapter 5. Healthcare CRO Market: Segment Analysis, By Service, 2016 - 2027 (USD Million)
5.1. Service market share analysis, 2019 & 2027
5.2. Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.3.1. Project Management/Clinical Supply Management
5.3.2. Data Management
5.3.3. Regulatory/Medical Affairs
5.3.4. Medical Writing
5.3.5. Clinical Monitoring
5.3.6. Quality Management/ Assurance
5.3.7. Bio-statistics
5.3.8. Investigator Payments
5.3.9. Laboratory
5.3.10. Patient and Site Recruitment
5.3.11. Technology
5.3.12. Others

Chapter 6. Healthcare CRO Market: Regional Market Analysis, 2016 - 2027 (USD Million)
6.1. Regional market share analysis, 2019 & 2027
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.4.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.4.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.4.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.4.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.5.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.9. Switzerland
6.5.9.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.9.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.10. Netherlands
6.5.10.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.10.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.11. Belgium
6.5.11.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.11.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.5.12. Austria
6.5.12.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.5.12.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.6.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.4. China
6.6.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.5. Japan
6.6.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.6. India
6.6.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.7. Australia
6.6.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.8. Korea
6.6.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.9. Thailand
6.6.9.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.9.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.10. Malaysia
6.6.10.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.10.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.11. Singapore
6.6.11.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.11.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.12. Indonesia
6.6.12.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.12.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.6.13. Taiwan
6.6.13.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.6.13.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7.4. Brazil
6.7.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7.5. Mexico
6.7.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7.6. Argentina
6.7.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7.7. Colombia
6.7.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.7.8. Chile
6.7.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.7.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8.4. South Africa
6.8.4.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8.5. Saudi Arabia
6.8.5.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8.6. UAE
6.8.6.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8.7. Israel
6.8.7.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
6.8.8. Iran
6.8.8.1. Market estimates and forecast, by type, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)

Chapter 7. Healthcare CRO Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. IQVIA
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Covance Inc.
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Pharmaceutical Product Development, LLC (PPD)
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PAREXEL
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Charles River Laboratories
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. ICON, plc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Medidata Solutions, Inc.
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Syneos Health.
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Pharmaron.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. GVK Biosciences Private Limited.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • IQVIA
  • Covance Inc.
  • Pharmaceutical Product Development, LLC (PPD)
  • PAREXEL
  • Charles River Laboratories
  • ICON, plc.
  • Medidata Solutions, Inc.
  • Syneos Health.
  • Pharmaron.
  • GVK Biosciences Private Limited.
Note: Product cover images may vary from those shown
Adroll
adroll